Genie Fertility is a London-based biotech startup developing non-invasive diagnostics for reproductive health, initially focusing on uterine health to improve IVF success rates. The company's ML multi-omics platform analyzes molecular markers in menstrual blood to provide clinicians with crucial, pain-free insights into the uterus lining's health, a critical factor often overlooked due to the invasiveness of traditional biopsy.